HSBC Holdings
FHTX icon

HSBC Holdings’s Foghorn Therapeutics FHTX Stock Holding History

HSBC Holdings’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,709
Closed -$66.6K – 3089
2025
Q1 		$66.6K Sell
18,709
-19
-0.1% -$87 ﹤0.01% 2873
2024
Q4 		$88.2K Buy
18,728
+2,061
+12% +$15K ﹤0.01% 2912
2024
Q3 		$158K Buy
16,667
+798
+5% +$5.78K ﹤0.01% 2696
2024
Q2 		$89.2K Buy
15,869
+78
+0.5% +$465 ﹤0.01% 2751
2024
Q1 		$106K Buy
15,791
+2,203
+16% +$12.2K ﹤0.01% 2834
2023
Q4 		$90.5K Buy
13,588
+16
+0.1% +$69 ﹤0.01% 2609
2023
Q3 		$70.7K Hold
13,572
– – ﹤0.01% 2597
2023
Q2 		$98.8K Hold
13,572
– – ﹤0.01% 2429
2023
Q1 		$83.3K Hold
13,572
– – ﹤0.01% 2528
2022
Q4 		$84.3K Buy
13,572
+2,972
+28% +$22.4K ﹤0.01% 2927
2022
Q3 		$92K Hold
10,600
– – ﹤0.01% 2758
2022
Q2 		$148K Hold
10,600
– – ﹤0.01% 2959
2022
Q1 		$163K Sell
10,600
-1,136
-10% -$15.6K ﹤0.01% 3035
2021
Q4 		$267K Sell
11,736
-9,056
-44% -$130K ﹤0.01% 2859
2021
Q3 		$284K Hold
20,792
– – ﹤0.01% 2578
2021
Q2 		$219K Buy
20,792
+2,050
+11% +$22.3K ﹤0.01% 2709
2021
Q1 		$251K Sell
18,742
-158
-0.8% -$2.59K ﹤0.01% 2415
2020
Q4 		$385K Buy
+18,900
New +$362K ﹤0.01% 2381

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HSBC Holdings's FHTX Position: Q2 2025 in Review

HSBC Holdings sold out of Foghorn Therapeutics (FHTX) in Q2 2025, closing a stake of 18,709 shares — an estimated $66.6K sold.

HSBC Holdings first reported a position in FHTX in Q4 2020 and held it in 18 quarters. The position peaked at $385K in Q4 2020. 81 funds tracked by Wall St. Rank hold FHTX as of Q2 2025.

  • HSBC Holdings reported no remaining Foghorn Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 18,709 Foghorn Therapeutics shares in Q2 2025, an estimated $66.6K.
  • HSBC Holdings first reported a position in Foghorn Therapeutics in Q4 2020 and held it in 18 quarters.
  • HSBC Holdings's Foghorn Therapeutics position peaked at $385K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.